BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32407145)

  • 1. Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
    Sean Ong XR; Condon B; Bagguley D; Lawrentschuk N; Azad A; Murphy D
    Future Oncol; 2020 Jul; 16(20):1409-1411. PubMed ID: 32407145
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.
    Massari F; Mollica V; Salvagni S; Tognetto M; Ardizzoni A
    Future Oncol; 2020 Jul; 16(20):1413-1415. PubMed ID: 32406749
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
    Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
    Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing Treatments for Cancer During the COVID-19 Pandemic.
    Muralidhar V; Dee EC; D'Amico AV
    Am J Clin Oncol; 2020 Jul; 43(7):457-458. PubMed ID: 32467526
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergency Open-source Three-dimensional Printable Ventilator Circuit Splitter and Flow Regulator during the COVID-19 Pandemic.
    Lai BK; Erian JL; Pew SH; Eckmann MS
    Anesthesiology; 2020 Jul; 133(1):246-248. PubMed ID: 32287047
    [No Abstract]   [Full Text] [Related]  

  • 6. Staying Ahead of the Wave.
    Singer AJ; Morley EJ; Henry MC
    N Engl J Med; 2020 Apr; 382(18):e44. PubMed ID: 32283005
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and The Prostate Cancer Connection.
    Gomella LG
    Can J Urol; 2020 Oct; 27(5):10346. PubMed ID: 33049184
    [No Abstract]   [Full Text] [Related]  

  • 8. Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?
    Fantin JPP; Facio MFW; Spessoto ACN; Spessoto LCF; Facio Junior FN
    Rev Assoc Med Bras (1992); 2020 Oct; 66(10):1314-1315. PubMed ID: 33174915
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen deprivation and SARS-CoV-2 in men with prostate cancer.
    Koskinen M; Carpen O; Honkanen V; Seppänen MRJ; Miettinen PJ; Tuominen JA; Raivio T
    Ann Oncol; 2020 Oct; 31(10):1417-1418. PubMed ID: 32615154
    [No Abstract]   [Full Text] [Related]  

  • 10. On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
    Caffo O; Zagonel V; Baldessari C; Berruti A; Bortolus R; Buti S; Ceresoli GL; Donini M; Ermacora P; Fornarini G; Fratino L; Masini C; Massari F; Mosca A; Mucciarini C; Procopio G; Tucci M; Verri E; Zucali P; Buttigliero C
    Ann Oncol; 2020 Oct; 31(10):1415-1416. PubMed ID: 32562741
    [No Abstract]   [Full Text] [Related]  

  • 11. How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?
    Chopra V; Toner E; Waldhorn R; Washer L
    Ann Intern Med; 2020 May; 172(9):621-622. PubMed ID: 32160273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can androgen deprivation therapy play a protective role in SARS-CoV-infections?].
    Schlack K; Krabbe LM
    Urologe A; 2020 Oct; 59(10):1251-1253. PubMed ID: 32776230
    [No Abstract]   [Full Text] [Related]  

  • 13. Does androgen deprivation therapy protect against severe complications from COVID-19?
    Patel VG; Zhong X; Liaw B; Tremblay D; Tsao CK; Galsky MD; Oh WK
    Ann Oncol; 2020 Oct; 31(10):1419-1420. PubMed ID: 32653425
    [No Abstract]   [Full Text] [Related]  

  • 14. Two Leaders.
    Czernin J
    J Nucl Med; 2020 Jun; 61(6):773. PubMed ID: 32499278
    [No Abstract]   [Full Text] [Related]  

  • 15. Ark of Life and Hope: the role of the Cabin Hospital in facing COVID-19.
    Shu L; Ji N; Chen X; Feng G
    J Hosp Infect; 2020 Jun; 105(2):351-352. PubMed ID: 32243949
    [No Abstract]   [Full Text] [Related]  

  • 16. Two Retrospective Analyses Show No Associated Adverse Outcomes With Delayed RP.
    Wright KM
    Oncology (Williston Park); 2020 Sep; 34(9):344-345. PubMed ID: 32965662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
    Carril-Ajuria L; Remolina-Bonilla YA; Carretero-Gonzalez A; Martin-Soberon M; Castellano D; Bourlon C; de Velasco G; Bourlon MT
    Oncology (Williston Park); 2020 Aug; 34(8):317-319. PubMed ID: 32785928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic.
    Ginsburg KB; Curtis GL; Timar RE; George AK; Cher ML
    J Urol; 2020 Oct; 204(4):720-725. PubMed ID: 32356508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Imperative of Early Treatment for Children With COVID-19 Infection.
    Elenga N
    Indian Pediatr; 2020 Jun; 57(6):587-588. PubMed ID: 32358228
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.
    Haines IE; Gabor Miklos GL
    J Natl Cancer Inst; 2013 Oct; 105(20):1534-9. PubMed ID: 24092918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.